Company record · updated October 7, 2026
Manus Bio Inc Cvt Pfd: 9 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs September 30, 2025 to June 30, 2026.
9observations
9source filings
9verified rows
2026-06-30most recent as-of date
Source rails for this company: N-PORT fund mark (9).
Reported by 3 filers: T. Rowe Price Health Sciences Fund, Inc., T. Rowe Price Health Sciences Portfolio, T. Rowe Price New Horizons Fund, Inc..
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2026-06-30 | price per share | 3.26 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 3987319.04 / balance 1223104.0 [series one-6] | 000109926326009596 |
| 2026-06-30 | price per share | 3.26 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 177663.48 / balance 54498.0 [series one-6] | 000109926326009591 |
| 2026-03-31 | price per share | 3 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 163494.0 / balance 54498.0 [series one-6] | 000109926326006593 |
| 2026-03-31 | price per share | 3 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 3669312.0 / balance 1223104.0 [series one-6] | 000109926326006598 |
| 2025-12-31 | price per share | 3 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 163494.0 / balance 54498.0 [series one-6] | 000109926326002544 |
| 2025-12-31 | price per share | 3 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 3669312.0 / balance 1223104.0 [series one-6] | 000109926326002549 |
| 2025-12-31 | price per share | 3 USD | T. Rowe Price New Horizons Fund, Inc. | VERIFIED | valUSD 5254623.0 / balance 1751541.0 [series one-6] | 000109926326002508 |
| 2025-09-30 | price per share | 3 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 3669312.0 / balance 1223104.0 [series one-6] | 000109926325003642 |
| 2025-09-30 | price per share | 3 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 163494.0 / balance 54498.0 [series one-6] | 000109926325003637 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price.